JDSNX
Price
$27.38
Change
-$0.27 (-0.98%)
Updated
Aug 20 closing price
Net Assets
1.27B
UBVVX
Price
$90.50
Change
+$0.56 (+0.62%)
Updated
Aug 21 closing price
Net Assets
9.03B
Interact to see
Advertisement

JDSNX vs UBVVX

JDSNX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
JDSNX vs. UBVVX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDSNX is a Hold and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.03B vs. JDSNX (1.27B). UBVVX pays higher dividends than JDSNX: UBVVX (1.59) vs JDSNX (0.57). JDSNX was incepted earlier than UBVVX: JDSNX (14 years) vs UBVVX (9 years). JDSNX (0.98) and UBVVX (0.94) have similar cost to investors . JDSNX is a more actively managed with annual turnover of: 37.00 vs. UBVVX (35.00). UBVVX has a lower initial minimum investment than JDSNX: UBVVX (0) vs JDSNX (1000000). JDSNX annual gain was more profitable for investors over the last year : 20.35 vs. UBVVX (8.29). UBVVX return over 5 years is better than : 20.79 vs. JDSNX (18.38).
JDSNXUBVVXJDSNX / UBVVX
Total Expense Ratio0.980.90109%
Annual Report Gross Expense Ratio0.980.94104%
Fund Existence14 years9 years-
Gain YTD17.00915.773108%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B9.03B14%
Annual Yield % from dividends0.571.5936%
Returns for 1 year20.358.29245%
Returns for 3 years25.1724.31104%
Returns for 5 years18.3820.7988%
Returns for 10 years43.52N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BHCHX23.570.16
+0.68%
Baron Health Care Instl
WILJX25.710.16
+0.63%
William Blair International Ldrs R6
CBFCX43.110.21
+0.49%
American Funds Global Balanced 529-C
JLPZX20.460.05
+0.24%
JPMorgan US Large Cap Core Plus R2
APDQX16.02N/A
N/A
Artisan Mid Cap Value Advisor